Mohammadhadi Khorrami

Mohammadhadi Khorrami

Auto-generated profile, based on publicly available information

Mohammadhadi Khorrami

Case Western Reserve Univ. (United States)

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Radiology
Verified
Journal Article
Closed access
NBNiha Beig
Niha Beig
MKMohammadhadi Khorrami
Mohammadhadi Khorrami
MAMehdi Alilou
Mehdi Alilou
PPPrateek Prasanna
Prateek Prasanna
NBNathaniel Braman
Nathaniel Braman
AMAnant Madabhushi
Anant Madabhushi
Perinodular and intranodular radiomic features corresponding to texture and shape (radiomics) were evaluated to distinguish non-small cell lung cancer adenocarcinomas from benign granulomas at nonc... PurposeTo evaluate ability of radiomic (computer-extracted imaging) features to distinguish non-small cell lung cancer adenocarcinomas from granulomas at noncontrast CT.Materials and MethodsFor thi...

1 January 2020 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
MKMohammadhadi Khorrami
Mohammadhadi Khorrami
PPPrateek Prasanna
Prateek Prasanna
AGAmit Gupta
Amit Gupta
PPPradnya Patil
Pradnya Patil
PVPriya D. Velu
Priya D. Velu
Anant MadabhushiAnant Madabhushi
Anant Madabhushi
No predictive biomarkers can robustly identify patients with non–small cell lung cancer (NSCLC) who will benefit from immune checkpoint inhibitor (ICI) therapies. Here, in a machine learning setting, we compared changes (“delta”) in the radiomic texture (DelRADx) of CT patterns both within and outside tumor nodules before and after two to three cycles of ICI therapy. We found that DelRADx patterns could predict response to ICI therapy and overall survival (OS) for patients with NSCLC. We retrospectively analyzed data acquired from 139 patients with NSCLC at two institutions, who were divided into a discovery set (D1 = 50) and two independent validation sets (D2 = 62, D3 = 27). Intranodular and perinodular texture descriptors were extracted, and the relative differences were computed. A linear discriminant analysis (LDA) classifier was trained with 8 DelRADx features to predict RECIST-derived response. Association of delta-radiomic risk score (DRS) with OS was determined. The association of DelRADx features with tumor-infiltrating lymphocyte (TIL) density on the diagnostic biopsies (n = 36) was also evaluated. The LDA classifier yielded an AUC of 0.88 ± 0.08 in distinguishing responders from nonresponders in D1, and 0.85 and 0.81 in D2 and D3. DRS was associated with OS [HR: 1.64; 95% confidence interval (CI), 1.22–2.21; P = 0.0011; C-index = 0.72). Peritumoral Gabor features were associated with the density of TILs on diagnostic biopsy samples. Our results show that DelRADx could be used to identify early functional responses in patients with NSCLC.

1 March 2019 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
MKMohammadhadi Khorrami
Mohammadhadi Khorrami
MKMonica Khunger
Monica Khunger
AZAlexia Zagouras
Alexia Zagouras
PPPradnya Patil
Pradnya Patil
Rajat ThawaniRajat Thawani
Rajat Thawani
AMAnant Madabhushi
Anant Madabhushi
PurposeTo identify the role of radiomics texture features both within and outside the nodule in predicting (a) time to progression (TTP) and overall survival (OS) as well as (b) response to chemotherapy in patients with non–small cell lung cancer (NSCLC).Materials and MethodsData in a total of 125 patients who had been treated with pemetrexed-based platinum doublet chemotherapy at Cleveland Clinic were retrospectively analyzed. The patients were divided randomly into two sets with the constraint that there were an equal number of responders and nonresponders in the training set. The training set comprised 53 patients with NSCLC, and the validation set comprised 72 patients. A machine learning classifier trained with radiomic texture features extracted from intra- and peritumoral regions of non–contrast-enhanced CT images was used to predict response to chemotherapy. The radiomic risk-score signature was generated by using least absolute shrinkage and selection operator with the Cox regression model; assoc...

1 September 2019 in Lung Cancer
Verified
Journal Article
Closed access
MKMohammadhadi Khorrami
Mohammadhadi Khorrami
PJPrantesh Jain
Prantesh Jain
KBKaustav Bera
Kaustav Bera
MAMehdi Alilou
Mehdi Alilou
RTRajat Thawani
Rajat Thawani
Anant MadabhushiAnant Madabhushi
Anant Madabhushi

23 November 2022 in Science Advances
Verified
Journal Article
Open access
MAMehdi Alilou
Mehdi Alilou
MKMohammadhadi Khorrami
Mohammadhadi Khorrami
PPPrateek Prasanna
Prateek Prasanna
KBKaustav Bera
Kaustav Bera
AGAmit Gupta
Amit Gupta
Anant MadabhushiAnant Madabhushi
Anant Madabhushi
Tumor vasculature is a key component of the tumor microenvironment that can influence tumor behavior and therapeutic resistance. We present a new imaging biomarker, quantitative vessel tortuosity (QVT), and evaluate its association with response and survival in patients with non–small cell lung cancer (NSCLC) treated with immune checkpoint inhibitor (ICI) therapies. A total of 507 cases were used to evaluate different aspects of the QVT biomarkers. QVT features were extracted from computed tomography imaging of patients before and after ICI therapy to capture the tortuosity, curvature, density, and branching statistics of the nodule vasculature. Our results showed that QVT features were prognostic of OS (HR = 3.14, 0.95% CI = 1.2 to 9.68, P = 0.0006, C-index = 0.61) and could predict ICI response with AUCs of 0.66, 0.61, and 0.67 on three validation sets. Our study shows that QVT imaging biomarker could potentially aid in predicting and monitoring response to ICI in patients with NSCLC.

18 April 2018 in Journal of Medical Imaging
Verified
Journal Article
Closed access
PDF file
MOMahdi Orooji
Mahdi Orooji
MAMehdi Alilou
Mehdi Alilou
SRSagar Rakshit
Sagar Rakshit
NBNiha G. Beig
Niha G. Beig
MKMohammad Hadi Khorrami
Mohammad Hadi Khorrami
Anant MadabhushiAnant Madabhushi
Anant Madabhushi
Differentiation between benign and malignant nodules is a problem encountered by radiologists when visualizing computed tomography (CT) scans. Adenocarcinomas and granulomas have a characteristic spiculated appearance and may be fluorodeoxyglucose avid, making them difficult to distinguish for human readers. In this retrospective study, we aimed to evaluate whether a combination of radiomic texture and shape features from noncontrast CT scans can enable discrimination between granulomas and adenocarcinomas. Our study is composed of CT scans of 195 patients from two institutions, one cohort for training (N = 139) and the other (N = 56) for independent validation. A set of 645 three-dimensional texture and 24 shape features were extracted from CT scans in the training cohort. Feature selection was employed to identify the most informative features using this set. The top ranked features were also assessed in terms of their stability and reproducibility across the training and testing cohorts and between scans of different slice thickness. Three different classifiers were constructed using the top ranked features identified from the training set. These classifiers were then validated on the test set and the best classifier (support vector machine) yielded an area under the receiver operating characteristic curve of 77.8%.